Sunday, February 28, 2021

Benefits of FDA 21 CFR Part 11

 


Benefits of FDA 21 CFR Part 11 provide an opportunity for medical device companies to reap the organizational advantages of paperless record-keeping systems. It also helps the FDA ensure that when medical device companies use electronic record-keeping systems, that document security and authenticity are adequately maintained.

The regulation sets out a framework for properly managing digital records so that they meet the requirements for regulatory inspection by the FDA. While facilitating regulatory oversight is the core focus by Benefits of FDA 21 CFR Part 11, the driving force behind it was, in fact, to ease the cost and burden of maintaining paper records to satisfy regulators.

  • Take out the testing requirement of the product, creation of the dossier, resolving the queries and after completion of all the activities.

Benefits of FDA 21 CFR Part 11 validation can be challenging depending on the type of quality management system you’re using, but it shouldn’t deter you from using a software of any sort to manage these functions.

Benefits of FDA 21 CFR Part 11 establishes the standard criteria under which the FDA considers electronic records, electronic signatures, and handwritten signatures executed to electronic records to be trustworthy, reliable, and generally equivalent to paper records and handwritten signatures executed on paper

It is meant to ensure the authenticity, integrity, and confidentiality of electronic records. These rules and regulations help to ensure robust and reliable study data that will stand up to the scrutiny of regulation and help to ensure future patient safety and effective medicines. Most companies have focused their Benefits of FDA 21 CFR Part 11 compliance efforts on manufacturing, on clinical trials, and on development, because that has been the focus of FDA auditing efforts. But it also makes good sense to design a discovery automation system to comply with Part 11.

What is US FDA 21 CFR Part 11?

FDA 21 CFR Part 11 allows medical device and life science organizations to use electronic records and signatures in place of paper.
The regulation applies to all aspects of the research, clinical study, maintenance, manufacturing, and distribution of medical products, and covers:

  • Required records that are maintained in electronic format in place of paper format
  • Required records that are maintained in electronic format in addition to paper format, and that are relied on to perform regulated activities
  • Records submitted to FDA in electronic format
  • Electronic signatures that are intended to be the equivalent of handwritten signatures.

Read More Article - 

Contact details –

Phone  no -  93702 83428

Mail id – enquiry@operonstrategist.com

Sunday, February 7, 2021

Turnkey Project Consultant For Medical Devices - Operon Strategist

 As Turnkey Project Consultant, we work on complex technical problems and guide in planning the medical device manufacturing plant layout which is to reduce the client’s costs and the effort for observing, individual coordination and planning to a minimum. Medical Device Turnkey Project Consultants means that our clients will receive a total turnkey approach to their investment project. Under the project idea, the Project need will be included and completely responsible for all technical coordination tasks with all other trades and client users.

THE BENEFITS OF A TURNKEY PROJECT

  • Can characterize the task-extension and results alongside us ahead of time.
  • Can define exactly the project scope and results with our expertise.
  • Can dedicate the project coordination activity with third parties like draftsmen, structural designers and contractors to us.


Operon Strategist is a medical device consulting has a team of trained professionals that work according to set standards and constantly upgrading their work techniques that assure meeting customer requirements timely and as per defined quality standards. To serve the diverse requirements of the clients we are the best Turnkey Project Consultant, wherein we assist our customers by offering comprehensive solutions to create Manufacturing Plant Layout Design that suits the client’s requests and requirements in their turnkey project while adhering to industry environmental standards, partner product installation standards and customer quality standards.

Read More Article - 

Contact details –

Phone  no -  93702 83428

Mail id – enquiry@operonstrategist.com

If  You Want Medical Devices Services Consultation For Following.

    2.     CDSCO Registration
    3.     FDA 510 k clearance
    5.     Design Control Requirements
    6.     QMS Certification Services

Friday, February 5, 2021

21 CFR Part 210 | 211 Quality Assurance -Operon Strategist


 In the 21 CFR Part 210 and 211, 21 CFR Part 210 deals with the Manufacturing, Processing, Packaging or  Holding of drugs, while 21 CFR Part 211 deals with finished pharmaceuticals. This cGMP Guidance related to the pharmaceutical and drug-related industry.

21 CFR Part 210 and 211

The move was in response to concerns about substandard drug manufacturing practices at the time. The 1962 Drug modification brought modern quality assurance and control principles to drug manufacturing. The word “current” was later added to make it “CGMP” (or cGMP) to imply that the regulation allows for changing technology in attaining GMP.

Operon Strategist helps in maintaining compliance with 21 CFR Part 210 and 21 CFR Part 211 which is critical to the pharmaceutical industry. This includes observation of current good manufacturing practice (cGMP) by understanding and planning the processes and methods defined in FDA Guidelines. We also help in the development of training modules for comprehension to various parts of the regulations, and also in the guide in strategic review and assessment of the organization for personal optimization. We also help our client In-depth system audits and recommendations for improvements, site inspection preparation activities and mock inspections.

Read More Article - 

Contact details –

Phone  no -  93702 83428

Mail id – enquiry@operonstrategist.com

CDSCO Import License for Medical Devices In India

  Central Drugs Standard Control Organisation is, known as CDSCO, is a regulatory body for the Indian medical devices industry, under the vi...